Clinical Trial Update: A Study of MLN8054 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of MLN8054 in patients with advanced solid tumors was terminated; the trial evaluated safety and dosing in breast cancer, colon cancer, pancreatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Colon Cancer
• Pancreatic Cancer

Drugs mentioned

• MLN8054 (MLN8054)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Breast Neoplasm, Colon Neoplasm | Phase 1 | Status: TERMINATED